Saruparib in HRDsig+ Solid Tumors
Saruparib in HRDsig+ Solid Tumors
Not yet recruiting · NCT07832630 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Saruparib in HRDsig+ Solid Tumors | neoplasm | Not yet recruiting | Phase 2 | 2026-09-22 | NCT07832630 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 137 |
| AstraZeneca | 806 |
| Basser Center for BRCA | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Abramson Cancer Center of the University of Pennsylvania | Philadelphia | United States | 47 |